ARCH Venture Fund IX, L.P.

13F Holdings History for Lyell Immunopharma, Inc. - Common Stock, par value $0.0001 per share (LYEL)

Symbol: LYEL on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 36.6M shares
Security Ownership: 13.1%

Robert Nelsen ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL)

2025-02-14 - Robert Nelsen has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 36.6M shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 per share (LYEL). This represents 13.1% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Robert Nelsen	13.1%		$16.1M	36.6M			$0.44	13G/A	12/31/2024	14 Feb 2025 16:55:23